last few days.
- OP for the last 4 days..
National Association of Realtors (NAR) Chief Economist Yun: Low rates had led many to seek to become landlords, inventory shortage in housing expected through next year- sees first Fed rate hike expected in Q4
Weekly Insider Trading Summary: CEOs active buyers in ...; Top execs seen selling
Buyers:
-
TransDigm Group (TDG) Director bought 278,080 shares at $109.03-191.02 worth ~ $53 mln
-
Seattle Genetics (SGEN) Director bought 546,252 shares at $37.41-38.92 worth ~ $20.9 mln
-
Comverse (CNSI) CEO, CFO, CAO, SVP and Director bought 107,165 shares at $23.09-23.69 worth ~ $2.5 mln
-
Endurance Specialty Holdings (ENH) CEO bought 20,330 shares at $51.67-51.76 worth ~ $1.1 mln
-
Independent Bank Group (IBTX) CEO, CFO, Chrmn and Directors (3) bought 10,250 shares at $48.78-49.32 worth ~ $500K
-
Orthofix International (OFIX) CFO bought 13,696 shares at $33.25 worth ~ $500K
-
Noble Corp (NE) CEO bought 10,000 shares at $31.03 worth ~ $300K
-
Winmark Corp (WINA) CEO bought 4,500 shares at $66.33 worth ~ $300K
-
WPX Energy (WPX) CEO bought 14,000 shares at $21.71 worth ~ $300K
-
Demandware (DWRE) Director Gen'l Catalyst Partners sold 300,000 shares at $60.26-61.82 worth ~ $18.2 mln
-
Patterson-UTI Energy (PTEN) Chairman and SVP sold 401,000 shares at $33.50-33.75 worth ~ $13.5 mln
-
Pioneer Natural Resources (PXD) CEO sold 20,000 shares at $220.00-221.75 worth ~ $4.4 mln
-
Calavo Growers (CVGW) CEO sold 85,819 shares at $34.00-34.48 worth ~ $5.2 mln
-
Magellan Midstream Partners (MMP) CEO sold 20,000 shares at $83.75-84.39 worth ~ $2.0 mln
-
Mobile Mini (MINI) CFO sold 35,000 shares at $47.70 worth ~ $2.0 mln
-
B&G Foods (BGS) CFO sold 55,000 shares at $33.93 worth ~ $2.0 mln
- Laredo Petroleum (LPI) CEO sold 70,000 shares at $28.93 worth ~ $2.0 mln
TW Telecom Inc Hearing strength attributed to circulation of reports of takeover interest from Level 3
Express up more than 20% on Sycamore Partners news; peers trading higher ( WTSL +4.8%, ARO +3%, AEO +1.9%, ZUMZ +2%, PSUN +1.7%, BKE +1.7%, APP +1.6%, ANF +0.8%, URBN +0.5%)
T-Mobile US CNBC's Faber: Sprint and T-Mobile have settled on a breakup fee for a potential deal
Gapping down
In reaction to disappointing earnings/guidance: FNSR -22%, CPST -3.8%.
Select EU financial related names showing weakness: NBG -2.3%, LYG -1.3%, CS -1.1%, ING -1%, DB -0.8%, HSBC -0.6%, SAN -0.5%.
Other news: ETRM -7.3% (FDA releases update from review of EnteroMedics' VBLOC implantable medical device), AXAS -3.3% (announces an acceleration in 2014 Eagle Ford activity and provide the following guidance update; Co raises production guidance to 5,800-6,000 Boepd, up from 5,500-5,700), COMM -3.3% (upsizes its secondary offering by 2.5 mln shares and prices 17.5 mln shares of common stock at $23.00 per share), QCOR -2% (Mallinckrodt (MNK) shareholders must consider risks of QCOR deal, according to reports), NVO -1.8% (still checking), TTM -1.4% (weak India markets today), DLNG -1.2% (priced public offering of 4.8 mln common units at $22.79 per unit), MT -1.1% (still checking), APAM -0.8% (announced secondary offering of ~1.84 mln shares of common stock by selling shareholders).
Analyst comments: CCG -2.4% (downgraded to Underperform from Neutral at BofA/Merrill), BLL -0.7% (downgraded to Neutral from Buy at BofA/Merrill), MRVL -0.6% (downgraded to Neutral from Positive at Susquehanna).
In reaction to disappointing earnings/guidance: FNSR -22%, CPST -3.8%.
Select EU financial related names showing weakness: NBG -2.3%, LYG -1.3%, CS -1.1%, ING -1%, DB -0.8%, HSBC -0.6%, SAN -0.5%.
Other news: ETRM -7.3% (FDA releases update from review of EnteroMedics' VBLOC implantable medical device), AXAS -3.3% (announces an acceleration in 2014 Eagle Ford activity and provide the following guidance update; Co raises production guidance to 5,800-6,000 Boepd, up from 5,500-5,700), COMM -3.3% (upsizes its secondary offering by 2.5 mln shares and prices 17.5 mln shares of common stock at $23.00 per share), QCOR -2% (Mallinckrodt (MNK) shareholders must consider risks of QCOR deal, according to reports), NVO -1.8% (still checking), TTM -1.4% (weak India markets today), DLNG -1.2% (priced public offering of 4.8 mln common units at $22.79 per unit), MT -1.1% (still checking), APAM -0.8% (announced secondary offering of ~1.84 mln shares of common stock by selling shareholders).
Analyst comments: CCG -2.4% (downgraded to Underperform from Neutral at BofA/Merrill), BLL -0.7% (downgraded to Neutral from Buy at BofA/Merrill), MRVL -0.6% (downgraded to Neutral from Positive at Susquehanna).
Gapping up
In reaction to strong earnings/guidance: INTC +6.9%.
M&A news: OPEN +13.1% prior to halt (will be acquired by Priceline (PCLN) for $103/share), CGG +7.8% (hearing BHI for CGG speculation as catalyst), PCLN +0.7% (acuiring OPEN for $103/share).
Select INTC peers/related names showing strength: AMD +2.3%, HPQ +1.7%, MSFT +1.3%, MSFT +1.3%, NVDA +0.9%.
Select OPEN peers trading higher: LIVE +14.7%, YELP +11.9%, GRPN +11.3%, GRUB +8.6%.
Select oil/gas related names showing strength: CEO +2.3%, SDRL +1.5%, RDS.A +1.1%, BP +1.1%, STO +0.9%, APA +0.9%, SNP +0.8%, TOT +0.5%.
Other news: ICLD +18.9% (announces it has become a VMware (VMW) partner and the opening of a New England Sales Office), NKTR +7.7% (Nektar Therapeutics confirms U.S. FDA advisory committee recommends no cardiovascular outcomes trial for peripherally-acting mu-opioid receptor antagonist (pamora) class including movantik), ARO +4.8% (higher following Sycamore Partners expressing interest in acquire Express), NEPT +4.1% (Sherbrooke plant to resume production), FCSC +4% (receives orphan drug designation for genetically-modified autologous human fibroblasts to advance treatment development for recessive dystrophic epidermolysis bullosa), BOTA +3.6% (CEO & President Russel Plumb purchases approx 32K shares at an avg price of $2.99; EVP, Corporate Dev & Strategies Jopseph Patti purchases approx 14K shares- Form 4 Filings, YGE +3.3% (Malaysia's largest operational solar power plant powered by over 10 MWs of Yingli Solar modules), P +3% (still checking), CHSP +2.2% (to replace JOSB in the S&P SmallCap 600), BOBE +1.9% (featured on Mad Money), XEC +1.6% (to replace IGT in the S&P 500), LGND +1.3% (partner GSK announces results of Phase 3 PETIT2 study of Eltrombopag ), BTG +1.1% (announces Otjikoto Project Update; additional high grade drill results from the Wolfshag Zone).
Analyst comments: BRC +4.9% (upgraded to Buy from Underperform at BofA/Merrill), FIO +3.3% (initiated with a Buy at ROTH Capital), NMBL +3.3% (upgraded to Strong Buy at Raymond James), MNKD +2.2% (initiated with Outperform and $16 tgt at RBC Capital Mkts), PVA +2% (upgraded to Buy from Hold at Stifel), SRCL +1.9% (upgraded to Outperform at Robert W. Baird), CMCM+1.6% (initiated with Outperform at OPCO), EDR +1% (upgraded to Buy from Neutral at BofA/Merrill)
In reaction to strong earnings/guidance: INTC +6.9%.
M&A news: OPEN +13.1% prior to halt (will be acquired by Priceline (PCLN) for $103/share), CGG +7.8% (hearing BHI for CGG speculation as catalyst), PCLN +0.7% (acuiring OPEN for $103/share).
Select INTC peers/related names showing strength: AMD +2.3%, HPQ +1.7%, MSFT +1.3%, MSFT +1.3%, NVDA +0.9%.
Select OPEN peers trading higher: LIVE +14.7%, YELP +11.9%, GRPN +11.3%, GRUB +8.6%.
Select oil/gas related names showing strength: CEO +2.3%, SDRL +1.5%, RDS.A +1.1%, BP +1.1%, STO +0.9%, APA +0.9%, SNP +0.8%, TOT +0.5%.
Other news: ICLD +18.9% (announces it has become a VMware (VMW) partner and the opening of a New England Sales Office), NKTR +7.7% (Nektar Therapeutics confirms U.S. FDA advisory committee recommends no cardiovascular outcomes trial for peripherally-acting mu-opioid receptor antagonist (pamora) class including movantik), ARO +4.8% (higher following Sycamore Partners expressing interest in acquire Express), NEPT +4.1% (Sherbrooke plant to resume production), FCSC +4% (receives orphan drug designation for genetically-modified autologous human fibroblasts to advance treatment development for recessive dystrophic epidermolysis bullosa), BOTA +3.6% (CEO & President Russel Plumb purchases approx 32K shares at an avg price of $2.99; EVP, Corporate Dev & Strategies Jopseph Patti purchases approx 14K shares- Form 4 Filings, YGE +3.3% (Malaysia's largest operational solar power plant powered by over 10 MWs of Yingli Solar modules), P +3% (still checking), CHSP +2.2% (to replace JOSB in the S&P SmallCap 600), BOBE +1.9% (featured on Mad Money), XEC +1.6% (to replace IGT in the S&P 500), LGND +1.3% (partner GSK announces results of Phase 3 PETIT2 study of Eltrombopag ), BTG +1.1% (announces Otjikoto Project Update; additional high grade drill results from the Wolfshag Zone).
Analyst comments: BRC +4.9% (upgraded to Buy from Underperform at BofA/Merrill), FIO +3.3% (initiated with a Buy at ROTH Capital), NMBL +3.3% (upgraded to Strong Buy at Raymond James), MNKD +2.2% (initiated with Outperform and $16 tgt at RBC Capital Mkts), PVA +2% (upgraded to Buy from Hold at Stifel), SRCL +1.9% (upgraded to Outperform at Robert W. Baird), CMCM+1.6% (initiated with Outperform at OPCO), EDR +1% (upgraded to Buy from Neutral at BofA/Merrill)
CGG grimpe de plus de 8% dans volumes d’échanges importants. L’américain Baker Hugues pourrait faire une offre sur la parapétrolière française, indique Bloomberg.
CGG affiche de loin la plus forte hausse duSRD en début d’après-midi, le titre de la parapétrolière grimpant de plus de 8% à 10,65 euros, après un gain de plus de 12% au plus haut de la séance. Les volumes sont plus de deux fois supérieurs à la normale. Selon, Jawaid Asfar, trader britannique chez Securequity, dont les propos sont relayés par l’agence Bloomberg, l’américain Baker Hughes envisagerait une offre sur le français. Un porte-parole de CGG interrogé par Bloomberg n’a pas souhaité commenter cette rumeur.
Dans la matinée, une autre information était évoquée par la même agence. Selon le magazine Upstream, la filiale WesternGeco de Schlumberger et CGG seraient en lice pour un contrat de sismique d’au moins 100 millions de dollars auprès de l’indien ONGC. Ce dernier serait prêt à débourser un total de 1,1 milliard de dollars pour relancer le champ offshore de Mumbai High. Et selon Upstream, le français pourrait être préféré car il aurait présenté un prix inférieur à son concurrent.
Plus généralement, l’ensemble du secteur pétrolier et parapétrolier est soutenu par la hausse des cours du pétrole, sur fond de tensions géopolitiques en Irak.